UK regenerative medicines company receives £1.2 million

Tuesday 20 October 2009

BioCeramic Therapeutics, a privately-owned company that is developing bioactive materials for orthopaedic and dental applications has received £1.2 million to support its operations ahead of the commercialisation of its lead product in 2010.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom